ME Therapeutics Holdings is a biotechnology based company which is currently focusing on the development of drugs that boost the body’s own immune system to defeat cancer – and they are calling it the next generation of “therapeutics targeting immune suppression”.
ME Therapeutics Holdings was listed on the Canadian Securities Exchange on October 12, 2023. In the duration span of less than a year, the share price of the company has increased more than 2500%. Given the fact that the company’s share price has seen an amazing growth in this short duration, should you invest in ME Therapeutics Holdings? Your all queries will be cleared when you read this article on ME Therapeutics Holdings (METX) Stock Price Prediction from 2024 – 2045.

Company’s current and upcoming goals:
The company is working on a new area of cancer research called Immuno Oncology. In recent times, the company has made strategic collaboration with another biotechnology company called NanoVation Therapeutics and has started clinical trials directly on the human body.
Another area that ME Therapeutics Holdings is focusing on is to target myeloid cells. Myeloid cells are a kind of immune cell whose function is to protect the body from infections – just like other immune cells do. However, these types of cells have another function which restricts the human body from killing the tumor cells. ME Therapeutics Holdings is developing a way by which the body will be able to restrict the particular function of the myeloid cells so that these cells don’t restrict the body from killing the tumor cells.
ME Therapeutics Holdings (METX) Stock Price Prediction 2024 – 2045
ME Therapeutics Holdings (METX) Stock Price Prediction | Prediction Price |
ME Therapeutics Holdings (METX) Stock Price Prediction 2024 | 1.22 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2025 | 1.235 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2026 | 1.337 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2027 | 1.448 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2028 | 1.568 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2029 | 1.698 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2030 | 1.839 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2035 | 2.740 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2040 | 4.083 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2045 | 6.083 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2024
The average price of the stock of ME Therapeutics Holdings (METX) for 2025 will be CAD 1.191, with a high forecast of CAD 1.235, and a lower forecast of CAD 1.148.
Month | Share price in CAD |
January | 1.20 |
February | 1.17 |
March | 4.40 |
April | 3.45 |
May | 3.99 |
June | 4.94 |
July | 4.91 |
August | 3.50 |
September | 1.50 |
October | 1.41 |
November | 1.35 |
December | 1.22 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2025
The average price of the stock of ME Therapeutics Holdings (METX) for 2025 will be CAD 1.191, with a high forecast of CAD 1.235, and a lower forecast of CAD 1.148.
Month | Share price in CAD |
January | 1.148 |
February | 1.155 |
March | 1.163 |
April | 1.171 |
May | 1.179 |
June | 1.186 |
July | 1.194 |
August | 1.202 |
September | 1.210 |
October | 1.218 |
November | 1.226 |
December | 1.235 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2026
The average price of the stock of ME Therapeutics Holdings (METX) for 2026 will be CAD 1.289, with a high forecast of CAD 1.337, and a lower forecast of CAD 1.243.
Month | Share price in CAD |
January | 1.243 |
February | 1.251 |
March | 1.259 |
April | 1.268 |
May | 1.276 |
June | 1.285 |
July | 1.293 |
August | 1.302 |
September | 1.311 |
October | 1.319 |
November | 1.328 |
December | 1.337 |
Suggested: Scottie Resources (SCOT) Stock Price Prediction from 2024 to 2045
ME Therapeutics Holdings (METX) Stock Price Prediction 2027
The average price of the stock of ME Therapeutics Holdings (METX) for 2027 will be CAD 1.396, with a high forecast of CAD 1.448, and a lower forecast of CAD 1.346.
Month | Share price in CAD |
January | 1.346 |
February | 1.355 |
March | 1.364 |
April | 1.373 |
May | 1.382 |
June | 1.391 |
July | 1.401 |
August | 1.410 |
September | 1.419 |
October | 1.429 |
November | 1.438 |
December | 1.448 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2028
The average price of the stock of ME Therapeutics Holdings (METX) for 2028 will be CAD 1.512, with a high forecast of CAD 1.568, and a lower forecast of CAD 1.458.
Month | Share price in CAD |
January | 1.458 |
February | 1.467 |
March | 1.477 |
April | 1.487 |
May | 1.497 |
June | 1.507 |
July | 1.517 |
August | 1.527 |
September | 1.537 |
October | 1.548 |
November | 1.558 |
December | 1.568 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2029
The average price of the stock of ME Therapeutics Holdings (METX) for 2029 will be CAD 1.638, with a high forecast of CAD 1.698, and a lower forecast of CAD 1.579.
Month | Share price in CAD |
January | 1.579 |
February | 1.589 |
March | 1.600 |
April | 1.611 |
May | 1.621 |
June | 1.632 |
July | 1.643 |
August | 1.654 |
September | 1.665 |
October | 1.676 |
November | 1.687 |
December | 1.698 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2030
The average price of the stock of ME Therapeutics Holdings (METX) for 2030 will be CAD 1.774, with a high forecast of CAD 1.839, and a lower forecast of CAD 1.710.
Month | Share price in CAD |
January | 1.710 |
February | 1.721 |
March | 1.733 |
April | 1.744 |
May | 1.756 |
June | 1.768 |
July | 1.779 |
August | 1.791 |
September | 1.803 |
October | 1.815 |
November | 1.827 |
December | 1.839 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2035
The average price of the stock of ME Therapeutics Holdings (METX) for 2035 will be CAD 2.643, with a high forecast of CAD 2.740, and a lower forecast of CAD 2.547.
Month | Share price in CAD |
January | 2.547 |
February | 2.564 |
March | 2.581 |
April | 2.599 |
May | 2.616 |
June | 2.633 |
July | 2.651 |
August | 2.669 |
September | 2.686 |
October | 2.704 |
November | 2.722 |
December | 2.740 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2040
The average price of the stock of ME Therapeutics Holdings (METX) for 2040 will be CAD 3.937, with a high forecast of CAD 4.083, and a lower forecast of CAD 3.795.
Month | Share price in CAD |
January | 3.795 |
February | 3.820 |
March | 3.846 |
April | 3.871 |
May | 3.897 |
June | 3.923 |
July | 3.949 |
August | 3.976 |
September | 4.002 |
October | 4.029 |
November | 4.056 |
December | 4.083 |
ME Therapeutics Holdings (METX) Stock Price Prediction 2045
The average price of the stock of ME Therapeutics Holdings (METX) for 2045 will be CAD 5.866, with a high forecast of CAD 6.083, and a lower forecast of CAD 5.654.
Month | Share price in CAD |
January | 5.654 |
February | 5.692 |
March | 5.730 |
April | 5.768 |
May | 5.806 |
June | 5.845 |
July | 5.884 |
August | 5.923 |
September | 5.963 |
October | 6.002 |
November | 6.043 |
December | 6.083 |
ME Therapeutics Holdings (METX) Stock Price – Historical Pricing
ME Therapeutics Holdings (METX) Stock Price in 2023 & 2024
ME Therapeutics Holdings (METX) Historical Pricing | Opening Price | Closing Price |
ME Therapeutics Holdings (METX) Stock Price in November 2023 | 0.050 CAD | 0.50 CAD |
ME Therapeutics Holdings (METX) Stock Price in December 2023 | 0.120 CAD | 1.20 CAD |
ME Therapeutics Holdings (METX) Stock Price in January 2024 | 1.20 CAD | 1.13 CAD |
ME Therapeutics Holdings (METX) Stock Price in February 2024 | 4.40 CAD | 4.40 CAD |
ME Therapeutics Holdings (METX) Stock Price in March 2024 | 3.45 CAD | 3.41 CAD |
ME Therapeutics Holdings (METX) Stock Price in April 2024 | 3.99 CAD | 3.96 CAD |
ME Therapeutics Holdings (METX) Stock Price in May 2024 | 4.94 CAD | 4.94 CAD |
ME Therapeutics Holdings (METX) Stock Price in June 2024 | 4.91 CAD | 3.71 CAD |
ME Therapeutics Holdings (METX) Stock Price in July 2024 | 3.50 CAD | 4.00 CAD |
ME Therapeutics Holdings (METX) Stock Price in August 2024 | 1.50 CAD | 2.75 CAD |
ME Therapeutics Holdings (METX) Stock Price in November 2023
In November 2023, the stock went live on the exchange on the very last week at the value of 0.050 CAD; it closed at 0.100 CAD.
ME Therapeutics Holdings (METX) Stock Price in December 2023
ME Therapeutics Holdings started its trading journey in December 2023 with a whopping 710% growth in the share price in a week as the price closed at 0.81 CAD. In the remaining 3 weeks of December, the share price indeed grew, but no move was more than 20%.
ME Therapeutics Holdings (METX) Stock Price in January 2024
The first week of January was the first week in the history of the stock when the stock closed in red. In the 3rd week of January too, the stock closed in red, at the value of 1.02 CAD.
ME Therapeutics Holdings (METX) Stock Price in February 2024
In the four weeks of February, the stock grew at a phenomenal rate; the difference between the opening price in February and the highest price of February was more than 455%. In February, the closing price of CSE METX was 2.97 CAD.
ME Therapeutics Holdings (METX) Stock Price in March 2024
Much like February, in March too, there was not a single week when the stock closed in red. However, the growth of the stock was much less than what the stock grew in February. The opening and the closing price were 3.00 CAD and 3.41 CAD.
ME Therapeutics Holdings (METX) Stock Price in April 2024
The first three weeks of April for CSE METX were mostly flat, it was only the 4th week when the stock moved 5.11% up, and closed at 3.96 CAD for April.
ME Therapeutics Holdings (METX) Stock Price in May 2024
In the last week of May, the shares of ME Therapeutics Holdings grew by 24.06% to close at 4.95 CAD.
ME Therapeutics Holdings (METX) Stock Price in June 2024
From the month of June, the share price of METX began to crash. It crashed 25.05% in June as METX closed at 3.71 CAD for June 2024.
ME Therapeutics Holdings (METX) Stock Price in July 2024
Though in the first week the share price rose, in the other weeks it went down so much that the price was ultimately pulled down to 4.00 CAD from 4.90 CAD (July’s high).
ME Therapeutics Holdings (METX) Stock Price in August 2024
ME Therapeutics Holdings (METX) stock started with a positive price growth in August. In this month, the price went from 3.50 CAD in the opening of August to 3.85 CAD by the end of the first week of August. However, in the 2nd week, the price of METX collapsed by 22.08% and in the last week the price stood at 2.75 CAD, as the stock said farewell to August.
ME Therapeutics Holdings (METX) Stock Technical Analysis:
Chart and trend analysis:
ME Therapeutics Holdings (METX) latest trend on monthly as well as on weekly time frame is strongly negative.
Support and resistance analysis:
Around the level of 1.00 CAD, CSE METX has a strong support. However, there isn’t any strong resistance in the chart of the company as of now.
ME Therapeutics Holdings (METX) Stock Fundamental analysis:
Financial overview:
CSE METX has a market cap of 32.75M CAD. Though METX is free from debt as of now, the free cash flow figures don’t seem impressive, given their continuous downfall.
Company performance:
As a small-cap company, METX doesn’t generate any profit. It generated -495.99K CAD net loss in the last 3rd quarter of this year, the previous quarter the number was at -143.49K CAD.
Disclaimer
The stock price predictions provided are hypothetical and not financial advice. The author and blog are not responsible for any financial losses. Always consult with a financial advisor and do your own research before investing.
FAQ
What should be the share price target of ME Therapeutics Holdings for 2025?
For 2025, the target for METX will be 1.337 CAD/share.

Welcome to PredictTorontoStocks! I’m Hilda J. Condit, a seasoned finance professional with a passion for the stock market and a deep-rooted connection to the Toronto Stock Exchange (TSX). With a Bachelor’s degree in Finance and specialized training from CSI Global Education’s Canadian Securities Course (CSC), I bring years of experience and expertise to the world of investment.
Over the years, I have had the privilege of working closely with the TSX, gaining valuable insights and building strong relationships with a diverse range of clients across Canada. My career has been dedicated to providing tailored investment advice and helping individuals and institutions navigate the complexities of the stock market.
In launching PredictTorontoStocks, my goal is to share my knowledge and offer precise stock price predictions to empower investors in making informed decisions. Drawing on my extensive experience and analytical skills, I am committed to delivering accurate forecasts and valuable insights that can help you achieve your investment goals.
Thank you for joining me on this journey. I look forward to contributing to your success in the dynamic world of Toronto stocks.